Viewing Study NCT00000658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:13 PM
Study NCT ID: NCT00000658
Status: COMPLETED
Last Update Posted: 2021-11-03
First Post: 1999-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None M-BACOD protocol View
None Granulocyte-Macrophage Colony-Stimulating Factor View
None Acquired Immunodeficiency Syndrome View
None Allopurinol View
None Antineoplastic Agents, Combined View